Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion

Diabetes

Volumn 47, Issue 1, 1998, Pages 45-49

  Pørksen, Niels ^a   Grøfte, Thorbjørn ^a   Nyholm, Birgit ^a   Holst, Jens Juul ^b   Pincus, Steven M ^c   Veldhuis, Johannes D ^d   Schmitz, Ole ^a   Butler, Peter C ^e  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c NSF Center for Biological Timing ^*  (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

^e UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCAGON LIKE PEPTIDE 1;

ADULT; AMPLITUDE MODULATION; ARTICLE; CONTROLLED STUDY; ENTROPY; HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INSULIN RELEASE; MALE; MATHEMATICAL ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; PULSATILE FLOW; STEADY STATE;

EID: 0031985801     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.1.45     Document Type: Article

References (30)

1. Holst JJ, Orskov C, Nielsen OV, Schwarz TW: Truncated glucagon-like peptide I, an insulin-releasing hormone from the distal gut. FEBS Lett 211:169-174, 1987
2. Mojsov S, Weir GC, Habener JF: Insulinotropin: glucagon-like peptide-I (7-37) co-encoded in the glucagon gene is a potent stimulator of insulin release in the perfused rat pancreas. J Clin Invest 79:816-619, 1987
3. Orskov C, Holst JJ, Poulsen SS, Kirkegaard P: Pancreatic and intestinal processing of proglucagon in man. Diabetologia 30:874-881, 1987
4. Thorens B: Expression cloning of the pancreatic β-cell receptor for the glucoincretin hormone glucagon-like peptide 1. Proc Natl Acad Sci USA 89:8641-8645, 1992
5. Anderson GE, Kologlu Y, Papadopoulus C: Fluctuations in postabsorptive blood glucose in relation to insulin release. Metabolism 16:586-596, 1967
6. Goodner CJ, Walike BC, Koerker DJ, Ensinck JW, Brown AC, Chideckel EW, Palmer J, Kalnasy L: Insulin, glucagon and glucose exhibit synchronous, sustained oscillations in fasting monkeys. Science 195:177-179, 1977
7. Porksen N, Munn S, Steers J, Vore S, Veldhuis J, Butler P: Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting. Am J Physiol 269:E478-E488, 1995
8. Porksen N, Nyholm B, Veldhuis JD, Butler PC, Schmitz O: In humans as least seventy-five percent of overall insulin secretion arises from punctuated high-frequency insulin secretory bursts. Am J Physiol. In press
9. Porksen N, Munn S, Steers J, Veldhuis JD, Butler PC: Effects of glucose ingestion versus infusion on pulsatile insulin secretion: the incretin effect is achieved by amplification of insulin secretory burst mass. Diabetes 45:1317-1323, 1996
10. Porksen N, Steers JL, Veldhuis JD, Butler PC: Effects of somatostatin on pulsatile insulin secretion: elective inhibition of insulin burst mass. Am J Physiol 270:E1043-E1049, 1996
11. Porksen N, Hussain MA, Nyholm B, Bianda TL, Butler PC, Christiansen JS, Veldhuis JD, Froesch ER, Schmitz O: Insulin-like growth factor I mediated inhibition of pulsatile insulin release is achieved by specific inhibition of the secretory burst mass at supraphysiologic and low IGF-I infusion rates in humans. Am J Physiol 272:E352-E358, 1997
12. Lang DA, Matthews DR, Burnett M, Turner RC: Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 30:435-439, 1981
13. O'Rahilly S, Turner RC, Matthews DR: Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes. N Engl J Med 318:1225-1230, 1988
14. Schmitz O, Porksen N, Nyholm B, Skjærbæk C, Butler PC, Veldhuis JD, Pincus SM: Evidence of disorderly and non-stationary insulin secretion in glucose tolerant relatives of NIDDM patients. Am J Physiol 272:E218-E226, 1997
15. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
16. Robertson RP: Defective insulin secretion in NIDDM: integral part of a multiplier hypothesis. J Cell Biochem 48:227-233, 1992
17. Holz GG IV, Kuhltreiber WM, Habener JF: Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37). Nature 361:362-365, 1993
18. Matthews DR, Naylor BA, Jones RG, Ward GM, Turner RC: Pulsatile insulin has greater hypoglycemic effect than continuous delivery. Diabetes 32:617-621, 1983
19. Komjati M, Bratusch-Marrain P, Waldhausl W: Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro. Endocrinology 118:312-319, 1986
20. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME: Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 39:578-582, 1993
21. Orskov C, Rabenhj L, Kood L, Wettergren A, Holst JJ: Production and secretion of amidated and glycine-extended glucagon-like peptide-1 (GLP-1) in man. Diabetes 43:535-539, 1994
22. Deacon CF, Johnsen AH, Holst JJ: Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo. J Clin Endocrinol Metab 80:952-957, 1995
23. Veldhuis JD, Carbon ML, Johnson ML: The pituitary gland secretes in bursts: appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations. Proc Natl Acad Sci USA 84:7686-7690, 1987
24. Van Cauter E, Mestrez F, Sturis J, Polonsky KS: Estimation of insulin secretion rates from C-peptide levels: comparison of individual and standard kinetic parameters for C-peptide clearance. Diabetes 41:368-377, 1992
25. Pincus SM: Approximate entropy as a measure of system complexity. Proc Natl Acad Sci USA 88:2297-2301, 1991
26. Pincus S, Singer BH: Randomness and degrees of irregularity. Proc Natl Acad Sci USA 93:2083-2088, 1996
27. Pincus S, Kalman RE: Not all (possibly) "random" sequences are created equal. Proc Natl Acad Sci USA 94:3513-3518, 1997
28. Porksen N, Munn S, Steers J, Schmitz O, Veldhuis JD, Butler PC: Mechanism of sulfonylurea's stimulation of insulin secretion in vivo: selective amplification of insulin secretory burst mass. Diabetes 45:1792-1797, 1996
29. Schmitz O, Pedersen SB, Mengel A, Porksen N, Bak J, Moller N, Richelsen B, Alberti KG, Butler PC, Orskov H: Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole-body glucose metabolism in obese subjects. Metabolism 43:842-846, 1994
30. Rachman J, Gribble FM, Barrow BA, Levy JC, Buchanan KD, Turner RC: Normalization of insulin responses to glucose by overnight infusion of glucagon-like peptide 1 (7-36) amide in patients with NIDDM. Diabetes 45:1524-1530, 1996